The hypomethylation of CpG sites in three proximal promoters determined CD133 expression in glioblastomas[42, 48] (delet: and hypermethylation of CD133 in HCT116 led to xenograft tumor formation in nude mice as compared to cells without CD133 methylation). The gene discussed is PROM1; the disease is glioblastoma.